세계의 첨단 창상 치료 시장 예측(-2030년) : 제품별, 창상 유형별, 최종사용자별, 지역별
Advanced Wound Care Market by Product (Dressings, NPWT, Debridement Devices, Biological Skin Substitutes, Topical Agents), Wound Type, End User, Region - Global Forecast to 2030
상품코드:1771769
리서치사:MarketsandMarkets
발행일:2025년 07월
페이지 정보:영문 376 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 첨단 창상 치료 시장 규모는 2025년 133억 7,000만 달러에서 2030년에는 193억 2,000만 달러에 달할 것으로 예측되며, 예측 기간 중 CAGR은 7.6%에 달할 것으로 보이고 있습니다.
조사 범위
조사 대상연도
2024-2030년
기준연도
2024년
예측 기간
2024-2030년
검토 단위
금액(10억 달러)
부문
제품별, 창상 유형별, 최종사용자별, 지역별
대상 지역
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카
고급 상처 치료 시장은 예측 기간 중 CAGR 7.6%를 보일 것으로 예측됩니다. 시장 성장의 주요 요인으로는 당뇨병 유병률 증가, 외상 및 화상 사례 증가, 만성 상처 상태 증가에 따른 노인 인구 증가 등이 있습니다.
최종사용자별로 고급 상처 치료 시장은 병원, ASC, 상처 치료 센터, 홈케어 환경, 기타 최종사용자로 구분되며, 2024년에는 병원, ASC, 상처 치료 센터 분야가 가장 큰 점유율을 차지할 것으로 예측됩니다. 당뇨병성 족부 궤양과 수술 상처 증가로 인해 병원에서는 주로 첨단 상처 관리 제품이 필요합니다. 또한 노인 인구 증가와 당뇨병 및 혈관 질환과 같은 만성질환의 유병률 증가로 인해 상처 치료를 위한 병원 방문이 증가하고 있습니다. 병원 및 기타 고급 상처 치료 센터에서는 확립된 프로토콜, 숙련된 의료진, 고급 상처 치료 제품을 사용하여 신속하고 효과적으로 상처를 치료할 수 있습니다.
상처 유형별로는 수술 및 외상성 상처, 당뇨병성 족부궤양, 욕창, 정맥성 하지궤양, 화상 및 기타 상처로 구분되며, 2024년 고급 상처 치료 시장은 수술 및 외상성 상처 부문이 가장 큰 비중을 차지할 것으로 예측됩니다. 이 부문의 점유율이 높은 이유는 고급 상처 치료 제품의 접근성이 높아졌기 때문입니다. 첨단 상처 치료 제품은 조기 회복을 촉진하고, 감염 위험을 줄이며, 조직 성장을 개선하므로 이러한 상처를 관리하는 데 특히 효과적입니다. 만성질환의 유병률 증가에 따른 외과수술 증가도 시장 성장에 기여할 것으로 예측됩니다.
세계 고급 상처 치료 시장은 5개 지역(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카)으로 구분됩니다. 아시아태평양의 성장은 수술 건수, 교통사고 건수, 화상 환자 수 증가에 기인하며, 이는 고급 상처 치료 수요에 영향을 미칠 것으로 예측됩니다. 또한 당뇨병 유병률 증가와 족부 궤양 환자 수 증가도 시장 성장을 가속할 가능성이 높습니다. 아시아태평양은 신흥 성장 국가로 시장 진출기업에게 높은 성장 기회를 제공합니다.
세계의 첨단 창상 치료 시장에 대해 조사했으며, 제품별, 창상 유형별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 개요
제4장 주요 인사이트
제5장 시장 개요
서론
시장 역학
고객 비즈니스에 영향을 미치는 동향/혼란
가격 분석
밸류체인 분석
공급망 분석
에코시스템 분석
투자와 자금조달 시나리오
기술 분석
특허 분석
무역 분석
2025-2026년의 주요 컨퍼런스와 이벤트
사례 연구 분석
규제 상황
Porter's Five Forces 분석
주요 이해관계자와 구입 기준
첨단 창상 치료 시장에서 AI의 영향
미국 관세 규제가 첨단 창상 치료 시장에 미치는 영향
제6장 첨단 창상 치료 시장(제품별)
서론
드레싱
디바이스와 액세서리
생물학적 피부 대체품
국소 약제
제7장 첨단 창상 치료 시장(창상 유형별)
서론
외과적·외상성 창상
당뇨병성 족궤양
욕창
정맥성 하지 궤양
화상, 기타
제8장 첨단 창상 치료 시장(최종사용자별)
서론
병원, ASCS, 창상관리 센터
홈케어
기타
제9장 첨단 창상 치료 시장(지역별)
서론
북미
북미의 거시경제 전망
미국
캐나다
유럽
유럽의 거시경제 전망
독일
영국
프랑스
이탈리아
스페인
러시아
기타
아시아태평양
아시아태평양의 거시경제 전망
중국
일본
인도
호주
한국
싱가포르
기타
라틴아메리카
라틴아메리카의 거시경제 전망
브라질
멕시코
기타
중동 및 아프리카
헬스케어 시설의 수요 증가가 시장을 촉진
중동 및 아프리카의 거시경제 전망
제10장 경쟁 구도
개요
주요 참여 기업의 전략/강점, 2024년
매출 분석, 2022-2024년
시장 점유율 분석, 2024년
기업 평가 매트릭스 : 주요 참여 기업, 2024년
기업 평가 매트릭스 : 스타트업/중소기업, 2024년
기업 평가와 재무 지표
브랜드/제품 비교
경쟁 시나리오
제11장 기업 개요
주요 참여 기업
SOLVENTUM
SMITH+NEPHEW
MOLNLYCKE AB
CONVATEC GROUP PLC
COLOPLAST GROUP
ORGANOGENESIS INC.
PAUL HARTMANN AG
CARDINAL HEALTH
MIMEDX GROUP, INC.
OWENS & MINOR
B. BRAUN SE
ESSITY AKTIEBOLAG
INTEGRA LIFESCIENCES CORPORATION
AVERY DENNISON CORPORATION
MATIV HOLDINGS, INC.
BIOVENTUS
ZIMMER BIOMET
기타 기업
LOHMANN & RAUSCHER GMBH & CO. KG
MEDLINE INDUSTRIES, LP
DEROYAL INDUSTRIES, INC.
WINNER MEDICAL CO., LTD.
ADVANCIS(UK)
MIL LABORATORIES PVT. LTD.
PENSAR MEDICAL
HAROMED BV
URGO GROUP
DIRECT HEALTHCARE GROUP
DERMARITE INDUSTRIES, LLC.
MEDAXIS LLC
GENTELL
제12장 부록
KSA
영문 목차
영문목차
The global advanced wound care market is projected to reach USD 19.32 billion by 2030 from USD 13.37 billion in 2025, at a CAGR of 7.6% during the forecast period."
Scope of the Report
Years Considered for the Study
2024-2030
Base Year
2024
Forecast Period
2024-2030
Units Considered
Value (USD billion)
Segments
Product, Wound Type, and End User
Regions covered
North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
The advanced wound care market is projected to grow at a CAGR of 7.6% during the forecast period. The key factors contributing to the market growth include the increasing prevalence of diabetes, the rising cases of traumatic & burn injuries, and the expanding geriatric population with a subsequent rise in chronic wound conditions.
By end user, the hospitals, ASCs, and wound care centers segment accounted for the largest share of the market in 2024.
By end user, the advanced wound care market is segmented into hospitals, ASCs, and wound care centers; home care settings; and other end users. In 2024, the hospitals, ASCs, and wound care centers segment accounted for the largest share of the market in 2024. The rising incidence of diabetic foot ulcers and surgical wounds primarily causes the need for advanced wound care products in hospitals. Hospital visits for wound care have also increased owing to the expanding geriatric population and the increasing incidence of chronic conditions, such as diabetes and vascular diseases. Hospitals and other advanced wound care centers can treat wounds quickly & effectively due to established protocols, knowledgeable medical staff, and the availability of advanced wound care products.
By wound type, the surgical & traumatic wounds segment accounted for the largest market share in 2024.
The market is segmented by wound type into surgical & traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns & other wounds. The surgical & traumatic wounds segment accounted for the largest share of the advanced wound care market in 2024. The large share of this segment is attributed to the availability of advanced wound care products, which are particularly effective in managing these wounds, as they promote quicker recovery, reduce infection risks, and improve tissue growth. The increasing number of surgical procedures owing to the rising incidence of chronic diseases is also expected to contribute to market growth.
By region, the Asia Pacific is expected to grow at the highest CAGR during the forecast period.
The global advanced wound care market is segmented into five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The growth of the Asia Pacific region can be attributed to the rising number of surgeries, road accidents, and burn cases, which is expected to influence the demand for advanced wound care therapies. The growing incidence of diabetes and rising cases of foot ulcers is also likely to fuel market growth. The Asia Pacific region offers high growth opportunities for players in the market owing to emerging growth economies.
A breakdown of the primary participants referred to for this report is provided below:
By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35%
By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
By Region: North America: 50%, Europe: 20%, the Asia Pacific: 20%, Latin America: 7%, and the Middle East & Africa: 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The key players operating in the advanced wound care market are Solventum (US), Smith+ Nephew (UK), Molnlycke AB (Sweden), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), B.Braun SE (Germany), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Essity, Aktiebolag (Sweden), AVERY DENNISON CORPORATION (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), Zimmer Biomet (US), and Bioventus (US).
Research Coverage
This report studies the advanced wound care market based on product, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments pertaining to five regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights into the following pointers:
Analysis of key drivers (growing geriatric population, increasing cases of traumatic injuries, growing prevalence of chronic diseases,
the rising incidence of burn injuries, and supportive
government initiatives & reimbursement policies), restraints (high cost of advanced wound care products and the risks associated with the use of advanced wound care products), opportunities (Emerging economies and the rising technological advancements in advanced wound care products), and challenges (shortage of trained professionals and limited awareness of advanced wound care products in rural areas)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the advanced wound care market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the advanced wound care market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the advanced wound care market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Approach 3: Primary interviews
2.2.1.4 Growth forecast
2.2.1.5 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.4.1 STUDY-RELATED ASSUMPTIONS
2.4.2 PARAMETRIC ASSUMPTIONS
2.4.3 GROWTH RATE ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ADVANCED WOUND CARE MARKET
4.2 ASIA PACIFIC: ADVANCED WOUND CARE MARKET SHARE, BY END USER AND COUNTRY
4.3 ADVANCED WOUND CARE MARKET, BY KEY COUNTRY
4.4 ADVANCED WOUND CARE MARKET, BY REGION, 2025 VS. 2030
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing geriatric population
5.2.1.2 Increasing cases of traumatic injuries
5.2.1.3 Growing prevalence of chronic diseases
5.2.1.4 Rising incidence of burn injuries
5.2.1.5 Government initiatives and reimbursement policies
5.2.2 RESTRAINTS
5.2.2.1 High cost of advanced wound care products
5.2.2.2 Risks associated with use of advanced wound care products
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging economies
5.2.3.2 Technological advancement in wound care
5.2.4 CHALLENGES
5.2.4.1 Lack of trained healthcare professionals
5.2.4.2 Limited awareness in underdeveloped regions
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
5.4.2 AVERAGE SELLING PRICE TREND, BY WOUND TYPE
5.4.3 AVERAGE SELLING PRICE TREND, BY REGION
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Negative pressure wound therapy
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 Micropore particle technology
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Telemedicine and mobile health (MHealth)
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA (HS CODE 300510)
5.11.2 EXPORT DATA (HS CODE 300510)
5.12 KEY CONFERENCES AND EVENTS, 2025-2026
5.13 CASE STUDY ANALYSIS
5.13.1 CASE STUDY 1: COMPLEX WOUND HEALING WITH TOPICAL ADVANCED WOUND CARE
5.13.2 CASE STUDY 2: EVALUATION OF NEW HYDROCOLL HYDROCOLLOID DRESSING IN WOUND CARE
5.13.3 CASE STUDY 3: SUPPORTED SELF-MANAGEMENT OF HARD-TO-HEAL PRESSURE ULCERS USING A SIMPLE 3-STEP FRAMEWORK DEVELOPED BY COLOPLAST
5.14 REGULATORY LANDSCAPE
5.14.1 REGULATORY ANALYSIS
5.14.1.1 North America
5.14.1.1.1 US
5.14.1.1.2 Canada
5.14.1.2 Europe
5.14.1.2.1 Germany
5.14.1.2.2 UK
5.14.1.2.3 France
5.14.1.3 Asia Pacific
5.14.1.3.1 China
5.14.1.3.2 Japan
5.14.1.3.3 India
5.14.1.4 Latin America
5.14.1.5 Middle East
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14.2.1 North America
5.14.2.2 Europe
5.14.2.3 Asia Pacific
5.14.2.4 Latin America
5.14.2.5 Rest of the World
5.15 PORTER'S FIVE FORCES ANALYSIS
5.15.1 BARGAINING POWER OF SUPPLIERS
5.15.2 BARGAINING POWER OF BUYERS
5.15.3 THREAT OF NEW ENTRANTS
5.15.4 THREAT OF SUBSTITUTES
5.15.5 INTENSITY OF COMPETITIVE RIVALRY
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 BUYING CRITERIA
5.17 IMPACT OF AI ON ADVANCED WOUND CARE MARKET
5.17.1 INTRODUCTION
5.17.2 MARKET POTENTIAL OF AI IN ADVANCED WOUND CARE MARKET
5.17.3 AI USE CASES
5.17.4 KEY COMPANIES IMPLEMENTING AI
5.17.5 FUTURE OF AI IN ADVANCED WOUND CARE MARKET
5.18 IMPACT OF US TARIFF REGULATION ON ADVANCED WOUND CARE MARKET
5.18.1 INTRODUCTION
5.18.2 KEY TARIFF RATES
5.18.3 PRICE IMPACT ANALYSIS
5.18.4 KEY IMPACTS ON COUNTRY/REGION
5.18.4.1 North America
5.18.4.2 Europe
5.18.4.3 Asia Pacific
5.18.5 IMPACT ON END-USE INDUSTRIES
5.18.5.1 Hospitals, ASCs, and wound care centers
6 ADVANCED WOUND CARE MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DRESSINGS
6.2.1 FOAM DRESSINGS
6.2.1.1 Silicone dressings
6.2.1.1.1 Ability to expedite wound closure and reduce risk of maceration to drive market
6.2.1.2 Non-silicone dressings
6.2.1.2.1 Advantages such as scar removal and wound healing to drive demand
6.2.2 HYDROCOLLOID DRESSINGS
6.2.2.1 Ability to promote granulation and formation of new tissues in open wounds to boost adoption
6.2.3 FILM DRESSINGS
6.2.3.1 Non-absorbable nature of film dressings to limit adoption
6.2.4 ALGINATE DRESSINGS
6.2.4.1 Growing incidence of pressure and diabetic foot ulcers to fuel growth
6.2.5 HYDROGEL DRESSINGS
6.2.5.1 Ability to provide relief and cooling effect on skin to drive use of hydrogel dressings
6.2.6 COLLAGEN DRESSINGS
6.2.6.1 Favorable reimbursement scenario for collagen dressings to support market
6.2.7 HYDROFIBER DRESSINGS
6.2.7.1 Combination of properties of hydrocolloids and alginates to boost adoption of hydrofiber dressings
6.2.8 WOUND CONTACT LAYERS
6.2.8.1 Ability to protect wound beds from bacterial and fungal growth to drive growth
6.2.9 SUPERABSORBENT DRESSINGS
6.2.9.1 Use of superabsorbent dressings for fragile skin to promote growth
6.2.10 OTHER ADVANCED DRESSINGS
6.3 DEVICES & ACCESSORIES
6.3.1 NPWT DEVICES & ACCESSORIES
6.3.1.1 Growing adoption of single-use NPWT devices in home care to drive growth
6.3.2 DEBRIDEMENT DEVICES & ACCESSORIES
6.3.2.1 Development of novel technologies to drive market
6.3.3 WOUND ASSESSMENT & MONITORING DEVICES
6.3.3.1 Potential cost-reducing capabilities of wound assessment & monitoring devices to boost adoption
6.3.4 OTHER DEVICES & ACCESSORIES
6.4 BIOLOGICAL SKIN SUBSTITUTES
6.4.1 HUMAN DONOR TISSUE-DERIVED PRODUCTS
6.4.1.1 High efficacy of human donor tissue-derived products to support market demand
6.4.2 ACELLULAR ANIMAL-DERIVED PRODUCTS
6.4.2.1 Recognition of importance of ECM in wound treatment to drive development of acellular wound care biologics
6.4.3 BIOSYNTHETIC PRODUCTS
6.4.3.1 Increased bioburden of infected wounds to drive development of biosynthetic wound care products
6.5 TOPICAL AGENTS
6.5.1 COST-EFFECTIVENESS AND EASE OF USE IN HOME CARE SETTINGS TO DRIVE DEMAND
7 ADVANCED WOUND CARE MARKET, BY WOUND TYPE
7.1 INTRODUCTION
7.2 SURGICAL & TRAUMATIC WOUNDS
7.2.1 RISING VOLUME OF SURGICAL PROCEDURES TO DRIVE MARKET
7.3 DIABETIC FOOT ULCERS
7.3.1 RISING DIABETES INCIDENCE TO DRIVE MARKET
7.4 PRESSURE ULCERS
7.4.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET
7.5 VENOUS LEG ULCERS
7.5.1 RISING PREVALENCE OF OBESITY TO DRIVE MARKET
7.6 BURNS & OTHER WOUNDS
7.6.1 HIGH INCIDENCE OF BURN INJURIES IN DEVELOPING REGIONS TO SUPPORT MARKET GROWTH
8 ADVANCED WOUND CARE MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS, ASCS, AND WOUND CARE CENTERS
8.2.1 INCREASING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE GROWTH
8.3 HOME CARE SETTINGS
8.3.1 DECREASED COSTS AND HIGHER CONVENIENCE AND COMFORT OF HOME CARE TO ENSURE MARKET GROWTH
8.4 OTHER END USERS
9 ADVANCED WOUND CARE MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 Rising diabetes prevalence and supportive reimbursement policies to drive market
9.2.3 CANADA
9.2.3.1 Government-backed efforts supporting market development
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Germany sees rising diabetes cases and chronic wound burden
9.3.3 UK
9.3.3.1 Increase in R&D activity to drive market
9.3.4 FRANCE
9.3.4.1 Rising chronic wound cases to drive market expansion
9.3.5 ITALY
9.3.5.1 Emerging market for advanced wound care in Europe
9.3.6 SPAIN
9.3.6.1 Rising life expectancy and aging population to drive demand
9.3.7 RUSSIA
9.3.7.1 Government initiatives to raise diabetes awareness to support market expansion
9.3.8 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 CHINA
9.4.2.1 Increasing incidence of diabetic foot ulcers (DFUs) to drive growth
9.4.3 JAPAN
9.4.3.1 Evolving healthcare delivery and infrastructure landscape to fuel market
9.4.4 INDIA
9.4.4.1 Booming medical tourism to speed up growth
9.4.5 AUSTRALIA
9.4.5.1 Growing medical manufacturing companies to drive market
9.4.6 SOUTH KOREA
9.4.6.1 Increasing healthcare spending to sustain growth
9.4.7 SINGAPORE
9.4.7.1 Increasing awareness and focus on advanced wound care therapies to facilitate growth
9.4.8 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Largest healthcare sector to drive market
9.5.3 MEXICO
9.5.3.1 Expanding hospital infrastructure to aid growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ADVANCED WOUND CARE MARKET
10.3 REVENUE ANALYSIS, 2022-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Product footprint
10.5.5.4 Wound type footprint
10.5.5.5 End user footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
